Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Metairie › NPI 1497792527
Hospital

University Healthcare System, L.C.

University Healthcare System, L.C. was paid $30.91M by Medicaid between Jan 2018 and Dec 2024, across 314 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.

33Billing provider infoUNIVERSITY HEALTHCARE SYSTEM, L.C.
METAIRIE, LA 70006
33aNPI1497792527assigned 05/31/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$30.91M
24GClaims1,094,406
24DCodes billed314
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#14 of 96
Median peer was paid$5.17M
This provider vs. median6.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018142,834$3.44M
2019125,446$3.29M
202095,291$2.46M
2021134,973$4.04M
2022176,736$5.41M
2023249,672$7.42M
2024incomplete169,454$4.86M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 22% 80,111 74,447 $6.65M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 68,487 61,640 $6.08M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 6.5% 69,599 52,691 $2.01M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.8% 11,569 10,168 $1.19M
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 2.4% 5,838 5,017 $739K
80053 Comprehensive metabolic panel 2.1% 86,661 71,894 $662K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 2.1% 8,821 7,857 $653K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.9% 21,002 19,035 $587K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.8% 14,912 13,423 $557K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1.8% 16,400 14,794 $547K
71045 Radiologic examination, chest; single view 1.8% 12,047 10,440 $543K
G0378 Hospital observation service, per hour 1.6% 3,251 2,523 $481K
302 more codes
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 1.5% 8,053 $466K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.4% 31,471 $446K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 8,187 $445K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.3% 13,028 $392K
85027 1.3% 84,723 $389K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.2% 11,332 $372K
99214 Doctor's office visit, returning patient (more involved) 1.2% 7,152 $360K
71046 Radiologic examination, chest; 2 views 1.1% 6,594 $354K
87481 1.1% 8,054 $350K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.1% 14,700 $346K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.1% 14,235 $345K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.1% 14,320 $344K
J7030 Infusion, normal saline solution , 1000 cc 1.1% 12,830 $337K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.1% 7,266 $334K
81025 <1% 44,234 $285K
76819 Fetal biophysical profile; without non-stress testing <1% 2,835 $247K
76801 <1% 2,609 $176K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 760 $174K
80081 <1% 2,263 $168K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 31,407 $166K
A0427 Emergency ambulance ride, advanced life support <1% 1,649 $164K
83735 <1% 33,247 $150K
84484 <1% 16,260 $148K
36415 Collection of venous blood by venipuncture <1% 57,857 $141K
83880 <1% 5,076 $123K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 5,988 $122K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,115 $111K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 554 $108K
81001 <1% 44,229 $106K
70450 Computed tomography, head or brain; without contrast material <1% 612 $103K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 17,859 $89K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,906 $86K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,564 $85K
86480 <1% 1,672 $84K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,769 $83K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,423 $81K
96375 Therapeutic injection; each additional sequential IV push <1% 6,551 $77K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,450 $75K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,727 $64K
87150 <1% 1,881 $63K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 10,989 $60K
72082 <1% 542 $59K
76536 <1% 666 $58K
A0429 Emergency ambulance ride, basic life support <1% 1,063 $56K
84443 Thyroid stimulating hormone (TSH) <1% 3,854 $55K
99215 Doctor's office visit, returning patient (complex) <1% 908 $43K
96361 Intravenous infusion, hydration; each additional hour <1% 3,314 $41K
31575 <1% 429 $39K
86803 <1% 3,043 $38K
93976 <1% 405 $37K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 142 $36K
83690 <1% 7,180 $36K
84100 <1% 10,482 $34K
84702 <1% 2,373 $32K
59025 Fetal non-stress test <1% 1,185 $31K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 411 $30K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 152 $30K
A0425 Ground mileage, per statute mile <1% 2,801 $28K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 44 $28K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,182 $27K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 114 $27K
86703 <1% 2,005 $23K
85610 <1% 8,075 $22K
99203 Doctor's office visit, new patient (routine) <1% 612 $21K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 10,448 $21K
92134 <1% 942 $19K
82677 <1% 844 $19K
36592 <1% 1,411 $18K
81002 <1% 6,425 $18K
93325 <1% 149 $18K
76820 <1% 311 $18K
36512 <1% 33 $18K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 618 $17K
80048 Basic metabolic panel (calcium, ionized) <1% 3,228 $16K
93320 <1% 113 $16K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 569 $16K
82105 <1% 967 $14K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 286 $14K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 611 $14K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 160 $14K
73630 <1% 421 $14K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 574 $13K
86336 <1% 843 $12K
87430 <1% 861 $11K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 368 $11K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 5,491 $11K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 327 $11K
82550 <1% 2,425 $10K
88142 <1% 742 $10K
83970 <1% 326 $10K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 151 $10K
76942 <1% 197 $9K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 14 $9K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 369 $9K
82950 <1% 1,997 $9K
77073 <1% 129 $9K
72190 <1% 102 $8K
82784 <1% 359 $8K
99204 Doctor's office visit, new patient (more involved) <1% 169 $8K
87807 <1% 669 $8K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 599 $8K
94060 <1% 170 $8K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,141 $7K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 16 $7K
87077 <1% 909 $7K
82947 <1% 1,918 $6K
73564 <1% 76 $6K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 87 $6K
74240 <1% 33 $6K
93017 <1% 45 $6K
72081 <1% 53 $6K
71250 <1% 14 $6K
86592 <1% 1,262 $6K
87040 <1% 562 $6K
76830 Ultrasound, transvaginal <1% 68 $5K
74019 <1% 91 $5K
84425 <1% 286 $5K
73610 <1% 167 $5K
99173 <1% 633 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 642 $4K
87340 <1% 501 $4K
82607 <1% 329 $4K
87081 <1% 641 $4K
86787 <1% 356 $4K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 30 $4K
80143 <1% 366 $4K
92133 <1% 278 $4K
82728 <1% 315 $4K
84207 <1% 250 $4K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 1,060 $3K
92551 <1% 480 $3K
83605 <1% 419 $3K
97167 <1% 102 $3K
77336 <1% 51 $3K
83550 <1% 438 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 13 $3K
97163 <1% 91 $3K
73030 <1% 61 $3K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 30 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,431 $3K
38222 <1% 14 $3K
80061 Lipid panel <1% 287 $3K
85730 <1% 792 $3K
G0475 Hiv antigen/antibody, combination assay, screening <1% 666 $2K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 787 $2K
82746 <1% 210 $2K
81003 <1% 1,517 $2K
82553 <1% 332 $2K
90837 Psychotherapy session, about an hour <1% 129 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 674 $2K
86334 <1% 203 $2K
P9016 Red blood cells, leukocytes reduced, each unit <1% 13 $2K
84439 <1% 245 $2K
90686 <1% 181 $2K
92083 <1% 141 $2K
83521 <1% 172 $2K
20552 <1% 109 $2K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 701 $2K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 28 $2K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 64 $2K
87186 <1% 225 $2K
86850 <1% 317 $2K
92557 <1% 82 $2K
92504 <1% 388 $2K
84446 <1% 137 $2K
36593 <1% 14 $2K
80074 <1% 97 $1K
91200 <1% 13 $1K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 20 $1K
73562 <1% 33 $1K
84165 <1% 232 $1K
85651 <1% 412 $1K
95950 <1% 12 $1K
82747 <1% 88 $1K
73560 <1% 60 $1K
86235 <1% 28 $1K
86140 <1% 352 $1K
94729 <1% 26 $1K
94727 <1% 30 $1K
83540 <1% 270 $1K
80320 <1% 2,346 $1K
84703 <1% 198 $1K
84590 <1% 116 $1K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 418 $1K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 833 $1K
87210 <1% 313 $1K
85045 <1% 268 $1K
87070 <1% 120 $964.84
83021 <1% 43 $929.16
81229 <1% 18 $900.04
J1650 Injection, enoxaparin sodium, 10 mg <1% 267 $876.25
86900 <1% 356 $875.91
86901 <1% 355 $853.58
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 47 $828.62
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 26 $809.87
86780 <1% 74 $797.00
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 130 $762.87
73130 <1% 14 $726.93
99201 <1% 34 $721.16
83020 <1% 64 $696.51
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 232 $693.64
90472 Immunization administration, each additional vaccine (list separately) <1% 2,302 $693.55
C1769 Guide wire <1% 598 $684.75
20610 <1% 84 $643.35
80197 <1% 189 $641.64
92567 <1% 56 $634.50
J2270 Injection, morphine sulfate, up to 10 mg <1% 313 $586.67
87563 <1% 98 $574.88
94664 <1% 19 $570.33
85018 <1% 213 $556.84
80050 General health panel <1% 16 $547.39
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,255 $531.97
87522 Neg quan hep c or qual rna <1% 13 $519.26
80305 <1% 58 $505.81
J1040 Injection, methylprednisolone acetate, 80 mg <1% 14 $480.56
86800 <1% 33 $455.64
86376 <1% 33 $419.72
84480 <1% 92 $406.50
84597 <1% 41 $390.97
87806 <1% 14 $385.91
82570 <1% 127 $376.77
83883 <1% 44 $360.17
86225 <1% 27 $347.82
86038 <1% 31 $342.36
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 111 $335.90
J0780 Injection, prochlorperazine, up to 10 mg <1% 12 $331.33
95012 <1% 40 $331.32
69210 <1% 29 $326.80
86902 <1% 14 $314.60
82951 <1% 24 $310.44
J1815 Injection, insulin, per 5 units <1% 78 $297.74
76514 <1% 29 $272.84
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 17 $256.36
84436 <1% 81 $255.92
88112 <1% 12 $229.28
88173 <1% 12 $223.72
84156 <1% 108 $222.65
G0379 Direct admission of patient for hospital observation care <1% 19 $221.65
93298 <1% 12 $206.82
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 591 $203.04
82726 <1% 18 $200.15
85379 <1% 35 $198.90
87799 <1% 73 $185.91
82962 <1% 202 $180.61
83615 <1% 55 $176.47
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 349 $159.23
82150 <1% 29 $155.11
92020 <1% 46 $154.97
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 28 $152.24
84153 <1% 14 $148.23
84478 <1% 26 $140.16
82525 <1% 22 $137.01
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 632 $135.47
80047 <1% 13 $132.78
92002 <1% 30 $128.92
84630 <1% 22 $125.75
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 60 $118.89
J1170 Injection, hydromorphone, up to 4 mg <1% 93 $113.07
82465 <1% 26 $98.88
80069 <1% 13 $86.80
82373 <1% 18 $86.58
J1030 Injection, methylprednisolone acetate, 40 mg <1% 12 $83.49
92556 <1% 12 $81.64
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 15 $80.53
88342 <1% 89 $74.40
82248 <1% 68 $73.00
82043 <1% 12 $64.42
90474 <1% 212 $54.15
36416 <1% 27 $51.18
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 14 $45.15
81000 <1% 18 $35.54
88313 <1% 38 $35.09
J1644 Injection, heparin sodium, per 1000 units <1% 316 $30.48
85652 <1% 12 $27.40
S0028 Injection, famotidine, 20 mg <1% 13 $26.88
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 28 $23.93
J0690 Injection, cefazolin sodium, 500 mg <1% 141 $18.90
99406 <1% 64 $17.32
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 351 $16.17
J2550 Injection, promethazine hcl, up to 50 mg <1% 27 $12.54
80329 <1% 211 $7.73
G0008 Administration of influenza virus vaccine <1% 30 $5.68
J3010 Injection, fentanyl citrate, 0.1 mg <1% 317 $4.94
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 51 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 63 $0.00
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) 0% 12 $0.00
99152 0% 32 $0.00
88280 0% 13 $0.00
88237 0% 14 $0.00
S5000 Prescription drug, generic 0% 15 $0.00
A9270 Non-covered item or service 0% 180 $0.00
V2632 Posterior chamber intraocular lens 0% 14 $0.00
C2623 Catheter, transluminal angioplasty, drug-coated, non-laser 0% 21 $0.00
88185 0% 13 $0.00
C1781 Mesh (implantable) 0% 14 $0.00
88184 0% 13 $0.00
88311 0% 14 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 33 $0.00
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) 0% 27 $0.00
88271 0% 13 $0.00
88264 0% 14 $0.00
88273 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCGAHA, ASHLEY (CFO)